Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Backed by Science: FDA-approved treatments with peer-reviewed evidence
Employer Considerations As the 2024 open enrollment season approaches, employers have several considerations before them: Exclude coverage: Employers might see lower drug costs and restrain any increase in member premiums by excluding the coverage of GLP-1 drugs approved for weight loss
It aggregates coupons and negotiated prices from pharmacies and presents you with the lowest available cash price at pharmacies near you
What GLP-1 Research Shows Beyond Weight Loss Research has identified benefits of certain incretin-based treatments beyond weight reduction, but the findings apply to specific medications, therapeutic doses and patient populations
Whats Inside
Our approach is personalized
US$ 27.79
US$ 23.64
US$ 25.40
